Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug...

Full description

Bibliographic Details
Main Authors: Rajeev Ramakrishna, Terrence H. Diamond, William Alexander, Arumugam Manoharan, Terry Golombick
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.2735
id doaj-0f7c75bb1dbe4aeca6c4a42b462bc37c
record_format Article
spelling doaj-0f7c75bb1dbe4aeca6c4a42b462bc37c2020-11-25T03:24:53ZengWileyClinical Case Reports2050-09042020-04-018473974410.1002/ccr3.2735Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapyRajeev Ramakrishna0Terrence H. Diamond1William Alexander2Arumugam Manoharan3Terry Golombick4Southern Sydney Haematology University of Wollongong Sydney NSW AustraliaDepartment of Endocrinology St George Hospital Kogarah NSW AustraliaSouthern Sydney Haematology University of Wollongong Sydney NSW AustraliaSouthern Sydney Haematology University of Wollongong Sydney NSW AustraliaDepartment of Endocrinology St George Hospital Kogarah NSW AustraliaAbstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.https://doi.org/10.1002/ccr3.2735curcumindexamethasone intolerancemultiple myeloma
collection DOAJ
language English
format Article
sources DOAJ
author Rajeev Ramakrishna
Terrence H. Diamond
William Alexander
Arumugam Manoharan
Terry Golombick
spellingShingle Rajeev Ramakrishna
Terrence H. Diamond
William Alexander
Arumugam Manoharan
Terry Golombick
Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
Clinical Case Reports
curcumin
dexamethasone intolerance
multiple myeloma
author_facet Rajeev Ramakrishna
Terrence H. Diamond
William Alexander
Arumugam Manoharan
Terry Golombick
author_sort Rajeev Ramakrishna
title Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_short Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_full Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_fullStr Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_full_unstemmed Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
title_sort use of curcumin in multiple myeloma patients intolerant of steroid therapy
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2020-04-01
description Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
topic curcumin
dexamethasone intolerance
multiple myeloma
url https://doi.org/10.1002/ccr3.2735
work_keys_str_mv AT rajeevramakrishna useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT terrencehdiamond useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT williamalexander useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT arumugammanoharan useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
AT terrygolombick useofcurcumininmultiplemyelomapatientsintolerantofsteroidtherapy
_version_ 1724599184416309248